| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.25B | 37.11B | 35.40B | 33.21B | 25.94B | 18.34B |
| Gross Profit | 9.48B | 9.60B | 9.68B | 9.38B | 6.17B | 2.08B |
| EBITDA | 19.92B | 21.53B | 21.18B | 19.61B | 14.59B | 9.76B |
| Net Income | 2.98B | 3.51B | 4.09B | 3.13B | 1.79B | 238.65M |
Balance Sheet | ||||||
| Total Assets | 85.75B | 75.36B | 69.44B | 72.26B | 62.96B | 54.74B |
| Cash, Cash Equivalents and Short-Term Investments | 14.66B | 11.69B | 11.80B | 15.69B | 11.22B | 11.11B |
| Total Debt | 18.47B | 13.77B | 14.13B | 20.99B | 19.49B | 19.36B |
| Total Liabilities | 30.12B | 21.43B | 20.43B | 30.06B | 26.40B | 23.70B |
| Stockholders Equity | 38.33B | 37.40B | 34.12B | 29.58B | 26.19B | 23.25B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.71B | 4.26B | 3.93B | 1.56B | 2.28B |
| Operating Cash Flow | 0.00 | 17.47B | 18.33B | 17.03B | 11.42B | 9.70B |
| Investing Cash Flow | 0.00 | -14.61B | -14.66B | -12.19B | -9.65B | -5.36B |
| Financing Cash Flow | 0.00 | -3.56B | -9.62B | -382.90M | -2.01B | -2.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥49.01B | 9.44 | ― | 3.02% | 10.24% | 61.61% | |
72 Outperform | ¥50.76B | 16.33 | ― | 1.98% | 3.60% | -17.45% | |
72 Outperform | ¥44.47B | 11.67 | ― | 1.48% | 36.31% | 101.77% | |
64 Neutral | ¥346.47B | 35.21 | ― | 1.09% | 29.60% | 24.39% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥38.56B | -217.53 | ― | 4.29% | -44.89% | -97.21% |